亮丙瑞林治疗子宫肌瘤的疗效及对 血清IGF-1、VEGF与性激素的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Efficacy of leuprolide in the treatment of uterine leiomyoma  and its effect on serum IGF-1, VEGF and sex hormone
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】目的 探讨亮丙瑞林治疗子宫肌瘤的疗效及对血清胰岛素样生长因子1(IGF1)、血管内皮生长因子(VEGF)与性激素的影响。方法 选择2016年4月~2017年5月期间收治的62例子宫肌瘤患者的临床资料,随机分为对照组和观察组,每组各31例,对照组采用米非司酮片治疗,观察组采用亮丙瑞林治疗。观察两组患者治疗后的临床疗效、不良反应发生情况和治疗前后的血清IGF1、VEGF及性激素水平。结果 观察组患者总有效率明显优于对照组,组间比较差异有统计学意义(P<0.05);治疗前,两组患者血清hsCRP、IGF1及VEGF水平比较无明显差异(P>005),但两组治疗后与治疗前相比明显降低(P<0.05),且观察组降低明显优于对照组(P<0.05);治疗前,两组患者雌二醇(E2)、孕酮(P)、绒毛膜促性腺激素(HCG)、黄体业成素(LH)、卵泡刺激素(FSH)、LH/FSH指标水平比较无明显差异(P>0.05),治疗后,两组患者E2、P、FSH指标水平与治疗前明显升高,HCG、LH、LH/FSH指标水平较治疗前明显下降(P<0.05),且观察组患者E2、P、FSH指标水平明显高于对照组,HCG、LH、LH/FSH指标水平明显低于对照组(P<0.05);两组患者不良反应均较轻,观察组的不良反应发生情况与对照组相比差异无统计学意义(P>0.05)。结论 亮丙瑞林治疗子宫肌瘤疗效显著,可有效降低血清IGF1、VEGF水平及改善血清E2、P、HCG、LH、FSH、LH/FSH水平,且毒副作用小,可在临床推广应用。

    Abstract:

    【Abstract】 Objective To explore the efficacy of leuprolide in the treatment of uterine leiomyoma and its effect on serum Insulinlike growth factor 1 (IGF1), vascular endothelial growth factor (VEGF) and sex hormone.Methods The clinical data of 62 patients with uterine fibroids admitted in our hospital from April 2016 to May 2017 were selected. 62 patients were divided into control group and observation group. The control group was treated with mifepristone tablets, and the control group was treated with leuprolide. The clinical efficacy and adverse reaction of the two groups after treatment were observed. The levels of serum IGF1, VEGF and sex hormones were observed before and after treatment in both groups.Results The total effective rate was 9355% in the observation group and 6774% in the control group (P<0.05). There were no significant differences in serum hsCRP, IGF1 and VEGF levels between the two groups before treatment (P>0.05). After treatment, the levels of serum hsCRP, IGF1F and VEG in the two groups were significantly lower than those before treatment (P<0.05), and the levels of serum hsCRP, IGF1 and VEGF in the control group were significantly higher than those in the observation group (P<0.05). Before treatment, there was no significant difference in the levels of E2, P, HCG, LH, FSH and LH / FSH between the two groups (P>0.05). After treatment, the levels of E2, P and FSH in both groups were significantly higher than those before treatment, and the levels of HCG, LH and LH / FSH were significantly lower than those before treatment (P<0.05). The levels of E2, P and FSH in the observation group were significantly higher than those in the control group. The levels of HCG, LH and LH / FSH in the observation group were significantly lower than those in the control group (P<0.05).The adverse reactions were mild in the two groups, and there was no significant difference between the two groups (P>0.05).Conclusion Leuprorelin can effectively reduce serum IGF1, VEGF levels and improve serum E2, P, HCG, LH, FSH and LH / FSH levels of uterine fibroids with small side effects.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-05-23
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司